CD27 defines phenotypically and functionally different human NK cell subsets

被引:138
作者
Vossen, Mireille T. M. [1 ,2 ]
Matmati, Mourad [1 ,3 ]
Hertoghs, Kirsten M. L. [1 ]
Baars, Paul A. [1 ]
Gent, Mi-Ran [1 ,2 ]
Leclercq, Georges
Hamann, Joerg [1 ]
Kuijpers, Taco W. [2 ]
van Lier, Rene A. W. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1100 DE Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, NL-1100 DE Amsterdam, Netherlands
[3] Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium
关键词
D O I
10.4049/jimmunol.180.6.3739
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The absence of the TNF-receptor family member CD27 marks the stable acquisition of cytolytic effector functions by both CD4(+) dim and CD8(+) T cells. We found that the majority of circulating human NK cells was CD27(-). These cells were largely CD56(dim), contained high levels of perforin and granzyme B, and were able to exert strong cytotoxic activity. In contrast, circulating CD27(+) NK cells were mostly CD56(dim/bright), had significant lower levels of perforin and granzyme B, and had a low cytolytic potential. Primary and secondary lymphoid organs were markedly enriched for CD27(+) NK cells. When correlating the expression of CD27 to recently defined developmental stages of NK cells in tonsil, we observed that CD27 was exclusively found on mature CD94(+), stage 4 NK cells. On these cells, regulation of CD27 expression appeared to be controlled by the common gamma-chain cytokine IL-15, and down-regulation of CD27 was specifically induced by its ligand, CD70. Thus, the absence of CD27 expression allows the definition of cytotoxic effector cells within the known mature NK cell subsets in humans.
引用
收藏
页码:3739 / 3745
页数:7
相关论文
共 45 条
  • [1] CD27/CD70 INTERACTION DIRECTLY DRIVES B-CELL IGG AND IGM SYNTHESIS
    AGEMATSU, K
    KOBATA, T
    YANG, FC
    NAKAZAWA, T
    FUKUSHIMA, K
    KITAHARA, M
    MORI, T
    SUGITA, K
    MORIMOTO, C
    KOMIYAMA, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (10) : 2825 - 2829
  • [2] Characterization of CD4+ CTLs ex vivo
    Appay, V
    Zaunders, JJ
    Papagno, L
    Sutton, J
    Jaramillo, A
    Waters, A
    Easterbrook, P
    Grey, P
    Smith, D
    McMichael, AJ
    Cooper, DA
    Rowland-Jones, SL
    Kelleher, AD
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (11) : 5954 - 5958
  • [3] Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNγ-mediated B cell depletion
    Arens, R
    Tesselaar, K
    Baars, PA
    van Schijndel, GMW
    Hendriks, J
    Pals, ST
    Krimpenfort, P
    Borst, J
    van Oers, MHJ
    van Lier, RAW
    [J]. IMMUNITY, 2001, 15 (05) : 801 - 812
  • [4] Properties of murine CD8+CD27- T cells
    Baars, PA
    Sierro, S
    Arens, R
    Tesselaar, K
    Hooibrink, B
    Klenerman, P
    van Lier, RAW
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (11) : 3131 - 3141
  • [5] Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
    Bauer, Stefan
    Groh, Veronika
    Wu, Jun
    Steinle, Alexander
    Phillips, Joseph H.
    Lanier, Lewis L.
    Spies, Thomas
    [J]. JOURNAL OF IMMUNOLOGY, 2018, 200 (07) : 2231 - 2233
  • [6] SEVERE HERPESVIRUS INFECTIONS IN AN ADOLESCENT WITHOUT NATURAL-KILLER CELLS
    BIRON, CA
    BYRON, KS
    SULLIVAN, JL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (26) : 1731 - 1735
  • [7] Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire
    Campbell, JJ
    Qin, SX
    Unutmaz, D
    Soler, D
    Murphy, KE
    Hodge, MR
    Wu, LJ
    Butcher, EC
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (11) : 6477 - 6482
  • [8] CD56bright human NK cells differentiate into CD56dim cells:: Role of contact with peripheral fibroblasts
    Chan, Antoni
    Hong, Deng-Li
    Atzberger, Ann
    Kollnberger, Simon
    Filer, Andrew D.
    Buckley, Christopher D.
    McMichael, Andrew
    Enver, Tariq
    Bowness, Paul
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 179 (01) : 89 - 94
  • [9] What does it take to make a natural killer?
    Colucci, F
    Caligiuri, MA
    Di Santo, JP
    [J]. NATURE REVIEWS IMMUNOLOGY, 2003, 3 (05) : 413 - 425
  • [10] The biology of human natural killer-cell subsets
    Cooper, MA
    Fehniger, TA
    Caligiuri, MA
    [J]. TRENDS IN IMMUNOLOGY, 2001, 22 (11) : 633 - 640